Doxorubicin enhances migration of leukemic cancer cells before cell death.
Doxorubicin and Daunorubicin stiffen and delay cells in mimicked microcirculation.
Some cancer drugs cause changes in cell mechanics that lead to pro-metastatic effects.
Cell mechanics becomes a new target for anti-metastatic drugs.